Brief: Bellus Health Announces Positive Interim Analysis From Phase 2B SOOTHE Trial Of BLU-5937 In Refractory Chronic Cough

BELLUS Health

13/09/2021 13:26

Sept 13 (Reuters) - BELLUS Health Inc  BLU.TO :
    * BELLUS HEALTH ANNOUNCES POSITIVE INTERIM ANALYSIS FROM THE
PHASE
2B SOOTHE TRIAL OF BLU-5937 IN REFRACTORY CHRONIC COUGH
    * BELLUS HEALTH INC - INTERIM ANALYSIS MET THRESHOLD FOR A
HIGH
PROBABILITY OF CLINICAL EFFICACY
    * BELLUS HEALTH INC - DATA FROM INTERIM ANALYSIS SUPPORT
ACCELERATED PLANNING FOR PHASE 3 PROGRAM
    * BELLUS HEALTH INC - SOOTHE PHASE 2B TRIAL IS ON TRACK TO
DELIVER
TOPLINE RESULTS IN Q4 2021
    * BELLUS HEALTH INC - LIMITED TASTE-RELATED ADVERSE EVENTS
WERE
OBSERVED, CONSISTENT WITH PREVIOUS BLU-5937 TRIALS
    * BELLUS HEALTH INC - NO SERIOUS ADVERSE EVENTS WERE
REPORTED

Source text for Eikon:  ID:nBwGc8Sfa 
Further company coverage:  BLU.TO 

 ((Reuters.Briefs@thomsonreuters.com;))